Adenosine deaminase in ischemia reperfusion injury in patients with myocardial infarction

References

• Kitakaze M, Minamino T, Node K, Takashima S, Funaya H, Kuzuya T, Hori M. Adenosine and cardioprotection in the diseased heart. Jpn Circ J 1999; 63: 231–243
   PubMedGoogle Scholar
• Verma S, Fedak PWM, Weisel RD, Butany J, Rao V, Maitland A, Li RK, Dhillon B, Yau TM. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 2002; 105: 2332–2336
   PubMed Web of Science ®Google Scholar
• Kaur G, Pandey NR, Chandra M, Sanwal GG, Misra MK. Lipid peroxidation in human blood platelets during unstable angina and myocardial infarction. Boll Chim Farmac 2000; 139: 267–269
   Google Scholar
• Donato M, Gelpi RJ. Adenosine and cardioprotection during reperfusion - an overview. Molec Cell Biochem 2003; 251: 153–159
   PubMed Web of Science ®Google Scholar
• Sommerschild HT, Kirkeboen KA. Adenosine and cardioprotection during ischaemia and reperfusion - an overview. Acta Anaesthes Scand 2000; 44: 1038–1055
   PubMed Web of Science ®Google Scholar
• Mattig S, Deussen A. Significance of adenosine metabolism of coronary smooth muscle cells. Am J Physiol Heart Circ Physiol 2001; 280: H117–H124
   Google Scholar
• Sommerschild HT, Grund F, Offstad J, Jynge P, Ilebekk A, Kirkeboen KA. Importance of endogenous adenosine during ischemia and reperfusion in neonatal porcine hearts. Circulation 1997; 96: 3094–3103
   Google Scholar
• Headrick JP, Hack B, Ashton KJ. Acute adenosinergic cardioprotection in ischemic - reperfused hearts. Am J Physiol Heart Circ Physiol 2003; 285: H1797–H1818
   PubMed Web of Science ®Google Scholar
• Bardenheuer H, Schrader J. Supply - to demand ratio for oxygen determines formation of adenosine by the heart. Am J Physiol Heart Circ Physiol 1986; 250: H173–H180
   Google Scholar
• Headrick J, Willis RJ. Relation between the O2 supply: demand ratio, MVO2, and adenosine formation in hearts stimulated with inotropic agents. Can J Physiol Pharmacol 1990; 68: 110–118
   PubMed Web of Science ®Google Scholar
• Daddona PE, Kelley WN. Human Adenosine Deaminase: Purification and subunit structure. J Biol Chem 1977; 252: 110–115
   PubMed Web of Science ®Google Scholar
• Snoeck E, Donck KV, Jacqmin P, Van Belle H, Dupout AG, Peer AV, Danhof M. Physiological red blood cell kinetic model to explain the apparent discrepancy between adenosine breakdown inhibition and nucleoside transporter occupancy of draflazine. J Pharmacol Exptl Therap 1998; 286: 142–149
   Google Scholar
• Mustafa SJ, Tewari CP. Latent adenosine deaminase in mouse brain: Exposure and solubilization of the mitochondrial enzyme. Biochim Biophys Acta 1970; 198: 93–100
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351–358
   PubMed Web of Science ®Google Scholar
• Tavazzi B, Pierro DD, Amorini AM, Fazzina G, Tuttobene M, Giardina B, Lazzarino G. Energy metabolism and lipid peroxidation of human erythrocytes as a function of increased oxidative stress. Eur J Biochem 2000; 267: 684–689
   PubMedGoogle Scholar
• Forman MB, Virmani R, Puett DW. Mechanism and therapy of myocardial reperfusion injury. Circulation 1990; 81: 69–78
   Google Scholar
• Maridonneau I, Braquet P, Garay RP. Na+ and K+ transport damage induced by oxygen free radicals in human red cell membranes. J Biol Chem 1983; 258: 3107–3113
   PubMed Web of Science ®Google Scholar
• Rohn TT, Nelson LK, Waeg G, Quinn MT. U-101033E (2,4- diaminopyrrolopyrimidine), a potent inhibitor of membrane lipid peroxidation as assessed by the production of 4-hydroxynonenal, malondialdehyde and 4-hydroxy nonenal -protein adducts. Biochem Pharmacol 1998; 56: 1371–1379
   PubMed Web of Science ®Google Scholar
• Snyder LM, Fortier NL, Leb L, Mckenney J, Trainor J, Sheerin H, Mohandas N. The role of membrane protein sulfhydryl groups in hydrogen peroxide -mediated membrane damage in human erythrocytes. Biochim Biophys Acta 1988; 937: 229–240
   PubMedGoogle Scholar
• Davies KJA, Goldberg AL. Oxygen radicals stimulate intracellular proteolysis and lipid peroxidation by independent mechanisms in erythrocytes. J Biol Chem 1987; 262: 8220–8226
   PubMed Web of Science ®Google Scholar
• Clarke DA, Davoll J, Philips FS, Brown GB. Enzymatic deamination and vasodepressor effects of adenosine analogs. J Pharmacol Exptl Therap 1952; 106: 291
   PubMed Web of Science ®Google Scholar
• Bunag RD, Douglas R, Imai S, Berne RM. Influence of a pyrimidopyrimidine derivative on deamination of adenosine by blood. Circ Res 1964; 15: 83–88
   PubMed Web of Science ®Google Scholar
• Berne RM. Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol 1963; 204: 317–322
   PubMed Web of Science ®Google Scholar
• Xia Y, Khatchikian G, Zweier JL. Adenosine deaminase inhibition prevents free radical - mediated injury in the postischemic heart. J Biol Chem 1996; 271: 10096–10102
   PubMed Web of Science ®Google Scholar
• Maggirwar SB, Dhanraj DN, Somani SM, Ramkumar V. Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun 1994; 201: 508–515
   PubMed Web of Science ®Google Scholar
• Oldroyd KG, Chopra M, Rankin AC, Belch JJ, Cobbe SM. Lipid peroxidation during myocardial ischemia induced by pacing. British Heart Journal 1990; 63: 88–92
   Google Scholar
• Davies SW, Ranjadayalan K, Wickens DG, Domandy TL, Timmis AD. Lipid peroxidation associated with successful thrombolysis. Lancet 1990; 335: 741–743
   PubMed Web of Science ®Google Scholar